Synapse - Alexia Iasonos

Results (363)

Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: A multicentre, first-in-patient, dose-escalation and dose-expansion, phase 1b trial

Journal Article

Pagel, J. M.; Soumerai, J. D.; Reddy, N.; Jagadeesh, D.; Stathis, A.; Asch, A.; Salman, H.; Kenkre, V. P.; Iasonos, A.; Llorin-Sangalang, J.; more...
Lancet Oncology (2022)

Fulltext@MSK | Save

Dual fluorescence isogenic synthetic lethal kinase screen and high-content secondary screening for MUC16/CA125-selective agents

Journal Article

Rao, T. D.; Xu, M.; Eng, S.; Yang, G.; Manson, R.; Rosales, N.; Kumar, R.; Veillard, I. E.; Zhou, Q.; Iasonos, A.; more...
Molecular Cancer Therapeutics (2022)

Fulltext@MSK | Save

Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas

Journal Article

Crowley, F.; Cadoo, K. A.; Chiang, S.; Mandelker, D. L.; Bajwa, R.; Iasonos, A.; Zhou, Q. C.; Miller, K. M.; Hensley, M. L.; O'Cearbhaill, R. E.
Gynecologic Oncology Reports (2022)

Fulltext@MSK | Save

Stopping rules for phase I clinical trials with dose expansion cohorts

Journal Article

Devlin, S. M.; Iasonos, A.; O’Quigley, J.
Statistical Methods in Medical Research (2022)

Fulltext@MSK | Save

Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer

Journal Article

Manning-Geist, B. L.; Gordhandas, S. B.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Lichtman, S. M.; Sabbatini, P. J.; more...
Gynecologic Oncology (2022)

Fulltext@MSK | Save

The effects of neoadjuvant chemotherapy and intervalde bulking surgery on body composition in patients with ovarian cancer

Journal Article

Vitarello, J.; Goncalves, M. D.; Zhou, Q. C.; Iasonos, A.; Halpenny, D. F.; Plodkowski, A.; Schwitzer, E.; Mueller, J. J.; Zivanovic, O.; Jones, L. W.; more...
JCSM Clinical Reports (2021)

Fulltext@MSK | Save

Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers

Journal Article

Choudhury, N. J.; Schneider, J. L.; Patil, T.; Zhu, V. W.; Goldman, D. A.; Yang, S. R.; Falcon, C. J.; Do, A.; Nie, Y.; Plodkowski, A. J.; more...
JTO Clinical and Research Reports (2021)

Fulltext@MSK | Save

Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers

Meeting Abstract

Choudhury, N. J.; Schneider, J. L.; Patil, T.; Zhu, V. W.; Goldman, D. A.; Yang, S. R.; Falcon, C.; Do, A.; Nie, Y.; Plodkowski, A. J.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort